Lida Mahfoozi
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
-
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 detection and testing 1
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Siavash Falahatkar (1 shared paper)Aliakbar Allahkhah (1 shared paper)Mohammad Shenagari (1 shared paper)Mohammadreza Naghipour (1 shared paper)Fariborz Mansour‐Ghanaei (1 shared paper)Saman Maroufizadeh (1 shared paper)Issa Jahanzad (1 shared paper)Farahnaz Joukar (1 shared paper)
- Journals
- Virology Journal (1 paper)Urolithiasis (1 paper)The Lancet (1 paper)DOAJ (DOAJ: Directory of Open Access Journals) (2 papers)
- Partner nations
- IranSwitzerlandJapan
In The Last Decade
Lida Mahfoozi
5 papers receiving 330 citations
Lida Mahfoozi's Hit Papers
Peers
Comparison fields: 5 of 65
- Infectious Diseases 185
- Neurology 55
- Critical Care and Intensive Care Medicine 9
- Obstetrics and Gynecology 10
- Pulmonary and Respiratory Medicine 41
Countries citing papers authored by Lida Mahfoozi
This map shows the geographic impact of Lida Mahfoozi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lida Mahfoozi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lida Mahfoozi more than expected).
Fields of papers citing papers by Lida Mahfoozi
This network shows the impact of papers produced by Lida Mahfoozi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lida Mahfoozi. The network helps show where Lida Mahfoozi may publish in the future.
Co-authors
The 9 scholars most cited alongside Lida Mahfoozi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses Hit paper breakdown → | 2022 | 289 |
| 2 | 2014 | 26 | |
| 3 | 2021 | 18 | |
| 4 | 2022 | 3 | |
| 5 | 2016 | 2 |
About Lida Mahfoozi
Lida Mahfoozi is a scholar working on Infectious Diseases, Neurology, Pediatrics, Perinatology and Child Health, Clinical Psychology and Public Health, Environmental and Occupational Health, having authored 5 papers that have together received 338 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (2 papers), Pediatric Urology and Nephrology Studies (1 paper), Kidney Stones and Urolithiasis Treatments (1 paper), Innovations in Medical Education (1 paper), Health and Well-being Studies (1 paper), Urinary Tract Infections Management (1 paper), SARS-CoV-2 detection and testing (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Infectious Diseases (185 citations), Neurology (55 citations), Critical Care and Intensive Care Medicine (9 citations), Obstetrics and Gynecology (10 citations) and Pulmonary and Respiratory Medicine (41 citations). Lida Mahfoozi has collaborated with scholars based in Iran, Switzerland and Japan. Frequent co-authors include Siavash Falahatkar, Aliakbar Allahkhah, Mohammad Shenagari, Mohammadreza Naghipour, Fariborz Mansour‐Ghanaei, Saman Maroufizadeh, Issa Jahanzad, Farahnaz Joukar and Aydin Pourkazemi. Their work appears in journals such as Virology Journal, Urolithiasis, The Lancet and DOAJ (DOAJ: Directory of Open Access Journals).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.